Location: Home
  • search
  • go
  • Relate News
  • 3/23/2023Roche, CR Pharma Tie Up to Improve Access of Flu Drug Xofluza in Chna
  • 3/23/2023Chinese Government Issues the Opinions for Further Improving Healthcar...
  • 3/23/2023CDE Solicits Comments on the Dossier Requirements for Marketing Regist...
  • 3/22/2023Biohaven Licenses ex-China Rights of Highlightll Pharma's TYK2/JAK1 Du...
  • 3/22/2023NMPA Issues Announcement for Applicability of ICH Guidelines S1B(R1)/Q...
  • 3/22/2023CDE Solicits Comments on the Technical Guidelines for Virus Removal/In...
  • 3/22/2023TaiGen Enters Exclusive License Agreement with Joincare for Pan-influe...
  • 3/21/2023Chinese NCE Drug Approval in 2022: Import vs. Domestic
  • 3/21/2023Review of Chinese Drug Registration Application and Evaluation in 2022
  • 3/21/2023Bayer, Orion's Nubeqa Gets Approval in China for Expanded Use in Prost...
  • 3/21/2023CDE Issues the Technical Guidelines for Clinical Research and Developm...
  • 3/21/2023CDE Issues the Technical Guidelines for Writing of Pharmacy Informatio...
  • 3/21/2023CDE Issues the Technical Guidelines for Continuous Manufacturing of Ch...
  • 3/21/2023Therapeutic Antibody Licensing Deals in China: A 2022 End-Of-Year Summ...
  • 3/20/2023New Report: China Cell Therapy Market Opportunity & Clinical Trials In...
  • 3/20/2023TOT Biopharm Terminates Development of Its HER2 ADC TAA013 in China Du...
  • 3/17/2023BeiGene Drops Licensing Option for Leap Thera's I/O Candidate DKN-01
  • 3/17/2023J&J and Legend Shelve Carvykti's UK Launch amid Manufacturing Shortfa...
  • 3/17/2023CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
  • 3/17/2023CDE Issues the Technical Guidelines for Clinical Trial of Compound Che...
  • 3/17/2023CDE Issues the Guidelines for Safety Information Summary, Analysis and...
  • 3/17/2023CDE Issues the FAQs for Rapid Reporting of Safety Data During Drug Cli...
  • 3/17/2023CDE Issues the Technical Guidelines for Abuse Prevention Pharmaceutica...
  • 3/17/2023Recent Executive Moves
  • 3/17/2023Jinyao Pharma Fined CNY 28M for Abuse of Market Dominance to Sell Chem...
  • 3/17/2023Drug R&D and Product Registration News Digest March 2023 (3)
  • 3/17/2023Upgrading Medtech Commercial Operations in China (McKinsey)
  • 3/16/2023China Biotech Fundraising Up Sharply in February as Six Drugmakers Iss...
  • 3/16/2023ArkBio and Calibr Collaborate on Potential First-in-class Drug for Res...
  • 3/16/2023Ahead of Pfizer Takeover, Seagen Quietly Sign Deal for Certain Cell Th...
  • Page:109/775 Total number of articles:23244: [First][<<] [107] [108] [109] [110] [111] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group